Page last updated: 2024-12-07
1192u90
Description
1192u90 doesn't appear to be a recognized term or concept in any scientific or research field. It's possible that:
* **It's a typo or misspelling:** There might be a similar term or code that you're trying to recall.
* **It's a specific jargon within a niche field:** If you can provide more context, like the field of study or the source where you encountered this term, I might be able to assist you further.
* **It's a fictional concept:** It's possible this term is made up and doesn't hold any scientific or research significance.
**To help me understand what you're looking for, please provide:**
* **The context where you found this term.**
* **Any related keywords or information you remember.**
Once you provide more details, I can help you find the relevant information or explain why this term doesn't seem to exist.
1192U90: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 127912 |
| CHEMBL ID | 1188853 |
| SCHEMBL ID | 9375707 |
| MeSH ID | M0259124 |
Synonyms (16)
| Synonym |
|---|
| PDSP1_001055 , |
| 2-amino-n-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide |
| 1192u90 |
| benzamide, 2-amino-n-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)- |
| PDSP2_001039 |
| L001475 |
| CHEMBL1188853 |
| glaxo 1192u90 |
| bdbm85048 |
| lle3y7vc87 , |
| unii-lle3y7vc87 |
| 155289-31-9 |
| SCHEMBL9375707 |
| DTXSID70165872 |
| 1192u90 free base |
| PD067598 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|
| "To assess the potential adverse effects in people of the antipsychotic agent 1192U90, we dosed mice, rats, beagles, and cynomolgus monkeys for up to 3 mo." | ( The experimental antipsychotic agent 1192U90 targets tapetum lucidum in canine eyes.
Dillberger, JE; Dykstra, MJ; O'Mara, M; Patel, DK; Peiffer, RL, ) | 0.63 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.50 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.45 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |